交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BristolMyers 新聞

陳昊然 2025 Aug 13, 00:00

Stifel 警告:關稅影響與經濟放緩恐引發股市修正

盧昕穎 2025 Aug 13, 00:00

通膨風險籠罩!聯準會降息預期面臨挑戰

林芷柔 2025 Aug 13, 00:00

彭博分析師:財政疑慮加劇,美元疲軟恐將持續

盧昕穎 2025 Aug 13, 00:00

黃金關稅豁免確認:市場展望與分析師觀點

陳昊然 2025 Aug 13, 00:00

美國7月CPI通膨報告:通膨升溫是否會推高利率?

黃達傑 2025 Aug 12, 16:00

AI股票CFD:交易NVDA股票CFD, 交易AMD股票CFD

黃達傑 2025 Aug 11, 16:00

觀察的納斯達克100指數ETF:QQQ、QQQM、TQQQ

黃達傑 2025 Aug 10, 16:00

加密市場波動性:AERO 價格上漲 30%,Solana 超過 $182

黃達傑 2025 Aug 07, 16:00

Fortinet 股票崩潰:為什麼 Fortinet 股票 (FTNT) 今天下跌?

黃達傑 2025 Jul 30, 16:00

生技股值得關注:EXEL、CRMD、HRMY、ETON、ATRA

最新新聞

顯示更多
陳昊然 2025 Aug 13, 00:00

澳洲央行降息:分析影響與市場預期

陳昊然 2025 Aug 13, 00:00

聯準會如何應對勞動市場數據疑慮:在不確定性中前行

張瑋庭 2025 Aug 13, 00:00

美國7月CPI:通膨數據是否強化聯準會降息預期?

陳昊然 2025 Aug 13, 00:00

波克夏海瑟威神秘持股揭曉:是 50 億美元的工業股投資?

許景桓 2025 Aug 13, 00:00

美國通膨展望:關稅、聯準會政策與黃金價格動態

張瑋庭 2025 Aug 13, 00:00

川普抨擊鮑爾,呼籲降息,通膨疑慮揮之不去

林芷柔 2025 Aug 13, 00:00

美國2024年7月消費者物價指數(CPI)分析:詳細分解

張瑋庭 2025 Aug 12, 03:20

美國七月 CPI 數據:風險重重的經濟展望解析

聯絡方式

點差

0.29

點差(%)

0.6116 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場開放

星期三

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

93487759360

流通股份

2035440000

收益日期(下一個)

2001-08-07

現金殖利率 

2025-08-01

除息日

2025-07-03

遠期年股息率

2.48

遠期年現金殖利率

0.054

每股盈餘

2.49

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Jul 27, 16:00

如何交易熱門股票CFD:FIX股票、LYEL股票、GNTX股票

黃達傑 2025 Jul 24, 16:00

Deckers 股票今日漲幅驚人:如何交易 DECK 股票 CFD?

黃達傑 2025 Jul 23, 16:00

趨勢股票CFD概述:TSLA CFD、Google CFD、RIVN CFD

Trustpilot